Newly established GeneaMed company is working on a new, potentially crucial drug on lympholytic leukemia. It is going to be based on dendrimers – particles used as transporters for drugs in vivo. The key in its lifesaving abilities is chemical modification inducing death of carcinogenic cells. ...
Read more